MucoLife Therapeutics
PrivateLast Round
Accelerator
Sep 6, 2024
Total Funding Raised
$30,000
Company Overview
MucoLife Therapeutics is a biotechnology company developing inhaled therapies for pulmonary mucus obstruction in chronic lung diseases such as COPD and cystic fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MucoLife Therapeutics Comparables
Compare MucoLife Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CILA Therapeutics | 88% | |
| Aer Therapeutics | 79% | |
| Synedgen, Inc. | 79% |
MucoLife Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 6, 2024 |
Key People
Founding team and executive leadership
MucoLife Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vasa Angels I | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 6, 2024
$30K round led by Health Wildcatters
MucoLife Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MucoLife Therapeutics's valuation, stock price, and market status.
Is MucoLife Therapeutics a public or private company?
MucoLife Therapeutics is a private company.
What is the current stock price of MucoLife Therapeutics?
MucoLife Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is MucoLife Therapeutics worth (valuation)?
Valuation information for MucoLife Therapeutics is not publicly available.
Can I buy MucoLife Therapeutics stock?
MucoLife Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MucoLife Therapeutics's last funding round?
MucoLife Therapeutics's most recent funding round was Accelerator on September 6, 2024.
Who are the main investors in MucoLife Therapeutics?
Key investors in MucoLife Therapeutics include Vasa Angels I.
Will MucoLife Therapeutics IPO soon?
No public IPO plans have been announced for MucoLife Therapeutics.
How can I track MucoLife Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MucoLife Therapeutics's secondary market activity and sign up for updates.